Clinical Trial Update: Radiogenomics of Muscle Invasive Bladder Cancer [NA]

View source ↗

Summary

A terminated clinical trial study on radiogenomics in muscle invasive bladder cancer was conducted; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Bladder Cancer Stage II | NA | Status: TERMINATED | Results posted: 2023-12-26